Skip to main content
Kukje Pharma Co., Ltd. logo

Kukje Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 002720 ISIN · KR7002720001 KO Manufacturing
Open in API
Filings indexed 297 across all filing types
Latest filing 2025-03-06 Proxy Solicitation & In…
Country KR South Korea
Listing KO 002720

About Kukje Pharma Co., Ltd.

https://www.kukjepharm.co.kr/index.php?…

Kukje Pharma Co., Ltd. is a company engaged in the manufacturing, distribution, import, and export of pharmaceutical products, cosmetics, and health supplements. Its core offerings include a wide range of prescription (ETC) and over-the-counter (OTC) drugs, with a notable specialization in antibiotics such as Cephalosporins. In addition to its primary pharmaceutical business, the company also develops and markets cosmetic products, food supplements, and respiratory protection face masks. The company serves both domestic and international markets.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Kukje Pharma. It outlines the date, location, and agenda items (approval of financial statements, election of directors, and director compensation). This type of document is sent to shareholders to provide information and request votes for the upcoming meeting, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2025-03-06 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date that coincides with other companies, which is a specific regulatory disclosure requirement in the Korean market. Since it does not fit into the specific categories of AGM materials, proxy statements, or voting results, and is a standard regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2025-03-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (stock pledge contracts) of major shareholders and special related parties of Kukje Pharm Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-03-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Kukje Pharma) announcing a significant change (over 30%) in revenue or profit structure. This is a standard preliminary financial disclosure required by the Korea Exchange (KRX) when financial results deviate significantly from the previous year. It provides key financial highlights (revenue, operating profit, net income) and explicitly states that these are preliminary figures subject to audit. As it is an initial announcement of financial results rather than a full annual report or a transcript, it falls under the 'Earnings Release' category. FY 2024
2025-02-24 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is an official announcement from Kukje Pharma regarding the determination of a record date for cash/in-kind dividends. It specifies the record date (2025-03-14) and explains the shareholder eligibility requirements for the upcoming dividend payment. This falls under the category of dividend announcements.
2025-02-24 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal corporate announcement regarding a 'Cash/In-kind Dividend Decision' (현금ㆍ현물 배당 결정) by Kukje Pharma. It specifies the dividend amount per share, the total dividend amount, the record date, and the board resolution date. This aligns perfectly with the definition for 'Notice of Dividend Amount' (DIV).
2025-02-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.